Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States
Federal Agencies Required to Buy Essential Medicines Domestically
What it does
Agencies must prioritize and increase domestic procurement of essential medicines, medical countermeasures, and critical inputs and identify supply-chain vulnerabilities.
Real-world impact
- Increases federal purchasing of medicines and medical supplies made in the United States.
- Requires agencies to report procurement, spending, and product sources annually.
- Allows the Defense Department to limit foreign suppliers for defense-related medical items.
Topics
Summary
This order directs federal agencies to increase U.S. production and purchasing of Essential Medicines, Medical Countermeasures, and Critical Inputs and to build redundancy in domestic supply chains. It aims to reduce dependence on foreign manufacturers and prevent shortages while protecting service members and patients.
It requires the Food and Drug Administration (FDA) to identify essential items and supply vulnerabilities, asks agencies to strengthen procurement rules and reporting, directs the Defense Department to prioritize military needs, and empowers use of existing authorities to speed domestic manufacturing.
Questions, answered
Ask questions about this executive order and its implications. Try:
- “What agencies are affected by this order?”
- “How does this order change existing policy?”
- “What are the practical implications of this order?”